Expression of VEGF and its receptors and angiogenesis in bone and soft tissue tumors

Anticancer Research

Volumn 26, Issue 6 B, 2006, Pages 4307-4311

  Hara, Hitomi ^a   Akisue, Toshihiro ^a   Fujimoto, Takuya ^a   Imabori, Masaya ^a   Kawamoto, Teruya ^b   Kuroda, Ryosuke ^a   Fujioka, Hiroyuki ^a   Yamamoto, Tetsuji ^b   Doita, Minoru ^a   Kurosaka, Masahiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Bone and soft tissue tumor; flt 1 and KDR; Microvessel density; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; BONE TUMOR; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOFT TISSUE TUMOR; TUMOR BIOPSY; TUMOR GROWTH; TUMOR VASCULARIZATION;

BONE NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SOFT TISSUE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846018575     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ferrara N: Vascular endothelial growth factor as a target for anticancer therapy. The Oncologist 9: 2-10, 2004.
2. Lee JC, Chow NH, Wang ST and Huang SM: Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 36: 748-753, 2000.
3. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N and Nakamura M: Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77: 998-1002, 1998.
4. Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocrinol Rev 18: 4-25, 1997.
5. Verheul HM, Hoekman K, Lupu F, Broxterman HJ, van der Valk P, Kakkar AK and Pinedo HM: Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res 6: 166-171, 2000.
6. Pakos EE, Goussia AC, Tsekeris PG, Papachristou DJ, Stefanou D and Agnantis NJ: Expression of vascular endothelial growth factor and its receptor, KDR/Flk-1, in soft tissue sarcomas. Anticancer Res 25: 3591-3596, 2005.
7. Potti A, Ganti AK, Foster H, Knox S, Hebert BJ, Tendulkar K, Sholes K, Koch M and Kargas S: Immunohistochemical detection of HER-2/neu, c-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas. Anticancer Res 24: 333-337, 2004.
8. Hayes AJ, Mostyn-Jones A, Koban MU, A'Hern R, Burton P and Thomas JM: Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma. Br J Surg 91: 242-247, 2004.
9. Gospodarowicz D, Abraham JA and Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86: 7311-7315, 1989.
10. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS and Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1983.
11. Spyridopoulos I, Brogi E, Kearney M, Sullivan AB, Cetrulo C, Isner JM and Losordo DW: Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. J Mol Cell Cardiol 29: 1321-1330, 1997.
12. Gerber HP, Dixit V and Ferrara N: Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273: 13313-13316, 1998.
13. Alon T, Hemo I, Itin A, Pe'er J, Stone J and Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1: 1024-1028, 1995.
14. Benjamin LE and Keshet E: Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94: 8761-8766, 1997.
15. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N and Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991, 1992.
16. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D and Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187: 1579-1586, 1992.
17. Toi M, Hoshina S, Takayanagi T and Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1049, 1994.
18. Fong GH, Rossant J, Gertsenstein M and Breitman ML: Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70, 1995.
19. Hanahan D: Signaling vascular morphogenesis and maintenance. Science 277: 48-50, 1997.
20. Shibuya M: VEGF-receptor inhibitors for anti-angiogenesis. Nippon Yakurigaku Zasshi 122: 498-503, 2003.
21. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR and Smith SK: Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 87: 506-516, 1995.
22. Ahmed A, Dunk C, Kniss D and Wilkes M: Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 76: 779-791, 1997.
23. Ergun S, Kilic N, Fiedler W and Mukhopadhyay AK: Vascular endothelial growth factor and its receptors in normal human testicular tissue. Mol Cell Endocrinol 131: 9-20, 1997.
24. Wen Y, Edelman JL, Kang T, Zeng N and Sachs G: Two functional forms of vascular endothelial growth factor receptor-2/Flk-1 mRNA are expressed in normal rat retina. J Biol Chem 273: 2090-2097, 1998.
25. Li QM, Kan FJ and Min CY: Effect of Weikangning on gastric cancer cell growth and expression of vascular endothelial growth factor and its receptors KDR and Flt-1. World J Gastroenterol 11: 938-942, 2005.
26. Neufeld G, Cohen T, Gengrinovitch S and Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999.
27. Niimi Y, Mochida S, Matsui A, Inao M and Fujiwara K: PKC- and MAPK-independent upregulation of VEGF receptor expressions in human umbilical venous endothelial cells following VEGF stimulation. Hepatol Res 21: 261-267, 2001.
28. Shen BQ, Lee DY, Gerber HP, Keyt BA, Ferrara N and Zioncheck TF: Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 273: 29979-29985, 1998.
29. Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C and Marme D: Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57: 5421-5425, 1997.
30. Beierle EA, Dai W, Langham MR Jr, Copeland III EM and Chen MK: Expression of VEGF receptors in cocultured neuroblastoma cells. J Surg Res 119: 56-65, 2004.
31. Yudoh K, Kanamori M, Ohmori K, Yasuda T, Aoki M and Kimura T: Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas. Br J Cancer 84: 1610-1615, 2001.
32. Iyoda A, Hiroshima K, Baba M, Fujisawa T, Yusa T and Ohwada H: Expression of vascular endothelial growth factor in thoracic sarcomas. Ann Thorac Surg 71: 1635-1639, 2001.
33. Kawauchi S, Fukuda T and Tsuneyoshi M: Angiogenesis does not correlate with prognosis or expression of vascular endothelial growth factor in synovial sarcomas. Oncol Rep 6: 959-964, 1999.
34. Sartelet H, Decaussin M, Devouassoux G, Nawrocki-Raby B, Brichon PY, Brambilla C and Brambilla E: Expression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1 [Flt-1] and VEGF-R2 [KDR/Flk-1]) in tumorlets and in neuroendocrine cell hyperplasia of the lung. Hum Pathol 35: 1210-1217, 2004.
35. Chao C, Al-Saleem T, Brooks JJ, Rogatko A, Kraybill WG and Eisenberg B: Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade. Ann Surg Oncol 8: 260-267, 2001.